|  | Received fluids vs Not received fluids | |||
---|---|---|---|---|---|
 | Units of comparison | Crude OR (95% CI) | Adjusted OR (95% CI) | Final Model Adjusted OR (95% CI) | P value1 |
Age | 5-year decrease | 1.05 (1.03 to 1.08) | 1.05 (1.03 to 1.07) | 1.05 (1.03 to 1.07) |  < 0.001 |
Men | vs Women | 0.96 (0.83 to 1.11) | 0.93 (0.79 to 1.08) | Â | Â |
Triage Category | |||||
 3–5 |  | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) |  |
 2 |  | 1.31 (1.12 to 1.52) | 1.09 (0.92 to 1.28) | 1.11 (0.94 to 1.3) | 0.240 |
 1 |  | 1.62 (1.2 to 2.18) | 1.23 (0.87 to 1.73) | 1.22 (0.87 to 1.71) | 0.217 |
mSOFA score | 1- unit increase | 1.12 (1.06 to 1.18) | 0.94 (0.87 to 1.02) | 1.11 (0.99 to 1.18) | 0.172 |
Lactate | 1Â mmol/L increase | 1.21 (1.14 to 1.29) | 1.07 (1.0 to 1.14) | 1.05 (0.98 to 1.12) | 0.179 |
Charlson Comorbidity Score | 1-unit increase | 0.94 (0.89 to 1.0) | 0.97 (0.92 to 1.03) | 0.91 (0.82 to 1.01) | 0.216 |
Septic shock Yes | vs No | 5.31 (3.6 to 7.82) | 1.94 (1.25 to 3.0) | 1.83 (1.15 to 2.9) | 0.011 |
ICU admission Yes | vs No | 01.26 (0.98 to 1.61) | 0.92 (0.69 to 1.23) | Â | Â |
Presentation hour | |||||
 0700-1500 h |  | 1.0 (Ref) | 1.0 (Ref) |  |  |
 1500-2300 h |  | 1.14 (0.96 to 1.35) | 1.13 (0.94 to 1.35) |  |  |
 2300-0700 h |  | 0.99 (0.78 to 1.26) | 0.97 (0.75 to 1.26) |  |  |
Lowest Systolic BP | 5 mmHg decrease | 1.14 (1.12 to 1.17) | 1.1 (1.09 to 1.13) | 1.11 (1.08 to 1.13) |  < 0.001 |
On Immunosuppressants Yes | vs No | 0.44 (0.19 to 1.04) | 0.4 (0.15 to 1.08) | 0.38 (0.15 to 0.96) | 0.037 |
On Steroids Yes | vs No | 0.87 (0.51 to 1.49) | 1.02 (0.54 to 1.95) | Â | Â |
Antibiotic administration time | 1-h increase | 0.99 (0.98 to 0.99) | 0.99 (0.98 to 1.0) | 0.99 (0.98 to 1.00) | 0.007 |
Hospital Sites Smaller Hospitals | vs larger hospitals | 1.28 (1.09 to 1.49) | 1.35 (1.14 to 1.6) | 1.48 (1.25 to 1.75) |  < 0.001 |
Clinical Rapid Response Alert Activated | 1- unit increase | 2.41 (1.97to 2.95) | 1.54 (1.2 to 1.98) | 1.64 (1.28 to 2.11) |  < 0.001 |
AUC | Â | Â | Â | 0.695 | Â |
N = 3094 |  |  |  |  |  |